Related Experiment Videos
[Positive inotropic substances in therapy of heart failure: digitalis, catecholamines, phosphodiesterase inhibitors]
1Kardiologischen Universitätsklinik Wien.
Insights
Inotropic agents for heart failure remain debated. Digitalis suits specific patients, while catecholamines aid acute cases and beta-blockers may help mild to moderate heart failure.
Area of Science:
- Cardiology
- Pharmacology
Context:
- Congestive heart failure (CHF) management involves ongoing discussion regarding optimal therapeutic strategies.
- Inotropic agents play a crucial role, but their specific indications and efficacies require clarification.
Purpose:
- To review and synthesize current evidence on the effects of various inotropic agents in treating patients with heart failure.
- To delineate the roles of digitalis, adrenoceptor agents, and phosphodiesterase inhibitors in managing CHF.
Summary:
- Digitalis is recommended for patients with impaired left ventricular function, supraventricular arrhythmias, or persistent symptoms despite diuretic and vasodilator therapy.
- Adrenoceptor stimulation (catecholamines) is established for acute, severe heart failure.
- Beta-receptor blockers show promise in mild to moderate CHF, suggesting a nuanced approach to their application.
Impact:
- Provides a comprehensive overview to guide clinical decision-making in heart failure pharmacotherapy.
- Highlights the differential efficacy of inotropic agents based on heart failure severity and patient characteristics.
- Informs future research directions for optimizing inotropic agent use in cardiovascular medicine.
Abstract:
The discussion about the importance of inotropic agents in the treatment of congestive heart failure is still open. A review of studies concerning the effects of digitalis, adrenoceptor stimulating or blocking agents, as well as phosphodiesterase inhibitors on hemodynamics and the physical state of heart failure patients is presented. Most authors agree that digitalis is indicated in patients with impaired left ventricular function and supraventricular arrhythmias, as well as in patients with heart failure who remain symptomatic during treatment with diuretics and vasodilators. While adrenoceptor stimulation with catecholamines is widely accepted in patients with acute and severe heart failure, beta-receptor blockers seem to have beneficial effects on some patients with mild to moderate congestive heart failure.